JP2021522296A5 - - Google Patents
Info
- Publication number
- JP2021522296A5 JP2021522296A5 JP2020561032A JP2020561032A JP2021522296A5 JP 2021522296 A5 JP2021522296 A5 JP 2021522296A5 JP 2020561032 A JP2020561032 A JP 2020561032A JP 2020561032 A JP2020561032 A JP 2020561032A JP 2021522296 A5 JP2021522296 A5 JP 2021522296A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- salt
- cells
- vaccination
- immunostimulant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024159173A JP2024170634A (ja) | 2018-04-30 | 2024-09-13 | 免疫増強剤としてのウロリチンａ |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1807051.6 | 2018-04-30 | ||
| GBGB1807051.6A GB201807051D0 (en) | 2018-04-30 | 2018-04-30 | Biological enhancer |
| GBGB1807819.6A GB201807819D0 (en) | 2018-05-14 | 2018-05-14 | Biological enhancer |
| GB1807819.6 | 2018-05-14 | ||
| PCT/EP2019/061093 WO2019211294A1 (en) | 2018-04-30 | 2019-04-30 | Urolithin a as immune enhancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024159173A Division JP2024170634A (ja) | 2018-04-30 | 2024-09-13 | 免疫増強剤としてのウロリチンａ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021522296A JP2021522296A (ja) | 2021-08-30 |
| JP2021522296A5 true JP2021522296A5 (enExample) | 2022-05-13 |
| JP7557374B2 JP7557374B2 (ja) | 2024-09-27 |
Family
ID=66379918
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020561032A Active JP7557374B2 (ja) | 2018-04-30 | 2019-04-30 | 免疫増強剤としてのウロリチンａ |
| JP2024159173A Pending JP2024170634A (ja) | 2018-04-30 | 2024-09-13 | 免疫増強剤としてのウロリチンａ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024159173A Pending JP2024170634A (ja) | 2018-04-30 | 2024-09-13 | 免疫増強剤としてのウロリチンａ |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10792276B2 (enExample) |
| EP (1) | EP3787615A1 (enExample) |
| JP (2) | JP7557374B2 (enExample) |
| CN (1) | CN112512517A (enExample) |
| BR (1) | BR112020022159A2 (enExample) |
| MX (2) | MX2020011619A (enExample) |
| WO (1) | WO2019211294A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3291904A1 (en) | 2012-06-27 | 2026-03-02 | Amazentis Sa | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
| JP7557374B2 (ja) | 2018-04-30 | 2024-09-27 | アマゼンティス エスアー | 免疫増強剤としてのウロリチンａ |
| JP7677893B2 (ja) * | 2019-01-18 | 2025-05-15 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 幹細胞機能を向上させるための薬剤及び方法 |
| GB201912107D0 (en) * | 2019-08-22 | 2019-10-09 | Amazentis Sa | Combination |
| US20240000747A1 (en) * | 2020-11-26 | 2024-01-04 | Daicel Corporation | Sirtuin 6 activator |
| WO2022162471A1 (en) | 2021-01-27 | 2022-08-04 | Vandria Sa | Urolithin derivatives and methods of use thereof |
| AU2022270331A1 (en) * | 2021-05-05 | 2023-10-12 | Ludwig Institute For Cancer Research | Urolithin for increasing stem cell function |
| CN113813255B (zh) * | 2021-10-20 | 2023-09-01 | 山东大学 | 尿石素a及其衍生物在肿瘤免疫治疗的应用 |
| GB202219317D0 (en) * | 2022-12-20 | 2023-02-01 | Amazentis Sa | Methods for improving mitophagy in subjects |
| GB202308224D0 (en) | 2023-06-01 | 2023-07-19 | Amazentis Sa | Formulation |
| CN117180267B (zh) * | 2023-10-25 | 2026-03-13 | 深圳市第三人民医院(深圳市肝病研究所) | 一种尿石素a在制备药物中的应用及药物 |
| WO2025224366A1 (en) * | 2024-04-26 | 2025-10-30 | Amazentis Sa | Immune health improvers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8183282B2 (en) | 2006-04-26 | 2012-05-22 | The Regents Of The University Of California | Therapeutic uses of urolithins |
| CA3291904A1 (en) * | 2012-06-27 | 2026-03-02 | Amazentis Sa | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
| US9394269B2 (en) | 2013-12-23 | 2016-07-19 | Amazentis Sa | Process-scale synthesis of urolithins |
| WO2016099947A1 (en) * | 2014-12-19 | 2016-06-23 | Halo Life Science, Llc | Use of ellagic acid dihydrate in food products and nutraceuticals |
| US20170304263A1 (en) * | 2016-04-20 | 2017-10-26 | John Michael Pezzuto | Antioxidative stress compositions, methods of preparing and uses thereof |
| WO2019163176A1 (ja) * | 2018-02-21 | 2019-08-29 | 株式会社ダイセル | ウロリチン類を含有する破骨細胞分化抑制剤 |
| JP7557374B2 (ja) | 2018-04-30 | 2024-09-27 | アマゼンティス エスアー | 免疫増強剤としてのウロリチンａ |
-
2019
- 2019-04-30 JP JP2020561032A patent/JP7557374B2/ja active Active
- 2019-04-30 US US16/398,956 patent/US10792276B2/en active Active
- 2019-04-30 WO PCT/EP2019/061093 patent/WO2019211294A1/en not_active Ceased
- 2019-04-30 BR BR112020022159-7A patent/BR112020022159A2/pt unknown
- 2019-04-30 CN CN201980044615.5A patent/CN112512517A/zh active Pending
- 2019-04-30 MX MX2020011619A patent/MX2020011619A/es unknown
- 2019-04-30 EP EP19721270.7A patent/EP3787615A1/en active Pending
-
2020
- 2020-10-01 US US17/061,265 patent/US11426380B2/en active Active
- 2020-10-30 MX MX2023013675A patent/MX2023013675A/es unknown
-
2022
- 2022-08-24 US US17/822,027 patent/US12109190B2/en active Active
-
2024
- 2024-09-13 JP JP2024159173A patent/JP2024170634A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522296A5 (enExample) | ||
| Altenburg et al. | Virus-specific T cells as correlate of (cross-) protective immunity against influenza | |
| JP2017523180A5 (enExample) | ||
| JP2021534183A5 (enExample) | ||
| TW200722101A (en) | Novel composition | |
| Hsu | A brief history of vaccines: smallpox to the present. | |
| JP2011504486A5 (enExample) | ||
| JP2009539965A5 (enExample) | ||
| JP2021505648A5 (enExample) | ||
| RU2017137357A (ru) | Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал | |
| Garg et al. | Alum adjuvanted rabies DNA vaccine confers 80% protection against lethal 50 LD50 rabies challenge virus standard strain | |
| JP2019112448A (ja) | ナイーブな対象のためのワクチン組成物 | |
| JP2011525902A (ja) | 遅延型追加刺激免疫処置に対する迅速な応答 | |
| CA3010049A1 (en) | Vaccine containing immobilized virus particles | |
| JP2024150687A (ja) | アジュバントおよび該アジュバントを含むワクチン | |
| Depelsenaire et al. | Introduction to vaccines and vaccination | |
| RU2016141621A (ru) | Способы усиления эффективности иммуностимуляции адсорбированных на соли алюминия вакцин | |
| Moingeon et al. | Therapeutic vaccines against infectious diseases | |
| Rehmani et al. | The influence of adjuvants on oral vaccination of chickens against Newcastle disease | |
| Modjarrad et al. | Human vaccines: emerging technologies in design and development | |
| CN101820904A (zh) | 引起针对大流行性流感病毒的免疫应答的方法 | |
| Adlard et al. | Influenza immunization in children with cystic fibrosis | |
| Hay | What you need to know | |
| US10034931B2 (en) | Use of EGFR pathway inhibitors to increase immune responses to antigens | |
| WO2020067302A1 (ja) | 粘膜アジュバント |